Burkina Faso vs Congo: HIV/AIDS deaths averted by antiretroviral therapy
Burkina Faso
4,383 deaths
in 2024
Congo
4,099 deaths
in 2024
Burkina Faso rank
41st
Congo rank
43rd
HIV/AIDS deaths averted by antiretroviral therapy over time
- Burkina Faso
- Congo
How they compare
Burkina Faso currently reports 4,383 deaths against 4,099 deaths in Congo, a difference of 284 deaths.
That makes Burkina Faso's figure about 1.1 times Congo's.
The two have swapped places 1 time across 35 shared years of data; in 1990 it was Congo ahead.
Burkina Faso ranks 41st and Congo ranks 43rd of 157 countries.
Burkina Faso has averaged higher in every one of the 4 decades both report.
Head to head by decade
| Decade | Burkina Faso | Congo | Difference | Ahead |
|---|---|---|---|---|
| 1990s | 0 deaths | 0 deaths | 0 deaths | — |
| 2000s | 1,688 deaths | 655.59 deaths | 1,032 deaths | Burkina Faso |
| 2010s | 4,403 deaths | 2,300 deaths | 2,103 deaths | Burkina Faso |
| 2020s | 4,350 deaths | 3,230 deaths | 1,121 deaths | Burkina Faso |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher hiv/aids deaths averted by antiretroviral therapy, Burkina Faso or Congo?
- Burkina Faso, at 4,383 deaths against 4,099 deaths in Congo as of 2024.
- What is the difference in hiv/aids deaths averted by antiretroviral therapy between Burkina Faso and Congo?
- 284 deaths, with Burkina Faso ahead.
- How many years of comparable data are there for Burkina Faso and Congo?
- 35 years are reported by both, from 1990 to 2024.
- How do Burkina Faso and Congo rank globally for hiv/aids deaths averted by antiretroviral therapy?
- Burkina Faso ranks 41st and Congo ranks 43rd of 157 countries.
- Where does this data come from?
- Joint United Nations Programme on HIV/AIDS (2026) – with minor processing by Our World in Data, published as HIV/AIDS deaths averted by antiretroviral therapy. Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Number of deaths prevented as a direct result of Antiretroviral Therapy (ART) among people living with HIV. It is calculated by comparing the observed mortality rates in individuals receiving ART to the estimated mortality rates in the absence of such treatment. This is the central estimate.